People · Operator
Named in public records as an officer, director or promoter · active 2010–2013 · Other, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| TNG Pharmaceuticals, Inc. | — | Other | Seed | $2.6M | $49.2M | 2013 |
| Xylogenics, Inc. | — | Biotechnology | Pre-Seed | $525K | $16.6M | 2010 |
Butch Mercer at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Butch Mercer on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Serge Martinod | 1 | 3 |
| Phoebe Wood | 1 | 3 |
| Larry Horn | 1 | 2 |
| Kent Van Kampen | 1 | 1 |
| Jennifer Corbin | 1 | 1 |
| Mike Neibler | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.